La Piattaforma Italiana per lo studio della Terapia delle Epatiti Virali (PITER): il primo grande studio nazionale sull'infezione cronica da virus dell'epatite C

(The Italian Platform for the study of Viral Hepatitis Therapies (PITER): the first national study on chronic HCV infection) - In order to address challenges and unanswered questions in the field of HCV therapy, the Italian Platform for the study of Viral Hepatitis Therapies (PITER), which is a strong collaboration among the Italian National Institute of Health (ISS), the Italian Association for the Study of the Liver (AISF) and the Italian Society of Infective and Tropical Diseases (SIMIT), launched as the first activity the PITER-HCV observational cohort study. Its main goal is to evaluate the direct acting antivirals (DAAs) short and long term outcomes in the patients’ real life, in order to optimize treatment protocols and to ensure the cure equity. The results of 6,058 first enrolled patients represent the first Italian snapshot of patients with chronic hepatitis C in care.